Fitness of acquired drug resistant Mycobacterium tuberculosis isolates from DOTS compliant patients
Authors:
- Purva BhatterPBPurva Bhatter
- Nerges MistryNMNerges Mistry
- 1 July 2013
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 93 (4) , 418-424
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2012
- Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, IndiaBMC Infectious Diseases, 2012
- Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genesNature Genetics, 2011
- Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosisClinical Microbiology and Infection, 2011
- Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in UgandaBMC Infectious Diseases, 2010
- Fitness Costs and Stability of a High-Level Ciprofloxacin Resistance Phenotype in Salmonella enterica Serotype Enteritidis: Reduced Infectivity Associated with Decreased Expression of Salmonella Pathogenicity Island 1 GenesAntimicrobial Agents and Chemotherapy, 2010
- Positive Epistasis Drives the Acquisition of Multidrug ResistancePLOS Genetics, 2009
- High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western IndiaBMC Public Health, 2009
- Tuberculosis Drug Resistance Mutation DatabasePLOS Medicine, 2009
- Biological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in JapanJournal of Clinical Microbiology, 2008